Daniel Bertges, MD
Vascular Surgery · Burlington, VTNPI 1619902368
Payments from drug & device makers
Across 20 payments — averaging $2907.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$46K
- Solventum Corporation$10K
- Silk Road Medical, Inc.$1K
- W. L. Gore & Associates, Inc.$295
- Medtronic$103
- Novo Nordisk$65
What the payments were for
- Travel & lodging$97756%
- Food & beverage$70240%
- Education$654%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 4 | $46,149 |
| Solventum Corporation | 2 | $10,250 |
| Silk Road Medical, Inc. | 8 | $1,280 |
| W. L. Gore & Associates, Inc. | 2 | $295 |
| Medtronic | 2 | $103 |
| Novo Nordisk | 2 | $65 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$1,168
- ENHANCE Transcarotid Peripheral Access Kit$1,168
- ENROUTE Transcarotid Stent System$1,063
- ENROUTE 0.014 Guidewire$1,063
- GORE VIABAHN Endoprosthesis with Heparin$173
- GORE TAG Conformable Thoracic Endoprosthesis$122
- ENROUTE Transcarotid Stent$105
- ENROUTE .014 Guidewire$105
How this compares
Too few vascular surgery providers in Vermontto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $17,339 |
| Cilostazol | 94 | $1,912 |
| ClopidogrelClopidogrel Bisulfate | 102 | $1,048 |
| Atorvastatin Calcium | 38 | $555 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Burlington
- Michael ParkerBurlington$11K
- Mead FerrisBurlington$6K
- Katelynn FerrantiBurlington$921
- Georg SteinthorssonBurlington$0
- Julie LahiriBurlington$0
- Andrew StanleyBurlington$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.